VASA: Vaccine Against Schistosomiasis for Africa. A Phase I clinical study of the SchistoShield anti schi...
INTERNATIONAL VACCINE INSTITUTE
participó en un
H2020:
H2020-SC1-BHC-2018-2020
Schistosomiasis is a poverty-related neglected tropical disease, impacting one billion people in 74 countries. Science ranked a schistosomia...
2019-05-06 - 2026-03-31 | financed
2019-05-06 - 2026-03-31 | financed
ZikaPLAN: Zika Preparedness Latin American Network
INTERNATIONAL VACCINE INSTITUTE
participó en un
H2020:
H2020-SC1-2016-2017
The ZikaPLAN initiative combines the strengths of 25 partners in Latin America, North America, Africa, Asia, and various centres in Europe t...
2016-11-16 - 2021-03-31 | financed
2016-11-16 - 2021-03-31 | financed
ATP: Access to Pharmaceuticals
INTERNATIONAL VACCINE INSTITUTE
participó en un
FP7:
Access to Pharmaceuticals Equitable access to pharmaceuticals, particularly for developing countries is an essential human right. Various co...
financed
financed
* No data from the current company are not available.